Howe & Rusling’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-48
| Closed | -$3K | – | 979 |
|
|
2020
Q4 | $3K | Buy |
48
+21
| +78% | +$1.31K | ﹤0.01% | 738 |
|
|
2020
Q3 | $2K | Hold |
27
| – | – | ﹤0.01% | 718 |
|
|
2020
Q2 | $2K | Buy |
+27
| New | +$2K | ﹤0.01% | 681 |
|
|
2019
Q1 | – | Sell |
-51
| Closed | -$4K | – | 854 |
|
|
2018
Q4 | $4K | Hold |
51
| – | – | ﹤0.01% | 569 |
|
|
2018
Q3 | $9K | Buy |
+51
| New | +$9K | ﹤0.01% | 528 |
|
|
2018
Q2 | – | Sell |
-2,140
| Closed | -$220K | – | 890 |
|
|
2018
Q1 | $220K | Hold |
2,140
| – | – | 0.04% | 163 |
|
|
2017
Q4 | $183K | Hold |
2,140
| – | – | 0.03% | 185 |
|
|
2017
Q3 | $182K | Hold |
2,140
| – | – | 0.03% | 182 |
|
|
2017
Q2 | $162K | Hold |
2,140
| – | – | 0.03% | 162 |
|
|
2017
Q1 | $141K | Hold |
2,140
| – | – | 0.03% | 174 |
|
|
2016
Q4 | $136K | Sell |
2,140
-64
| -3% | -$4.07K | 0.03% | 175 |
|
|
2016
Q3 | $140K | Hold |
2,204
| – | – | 0.03% | 167 |
|
|
2016
Q2 | $164K | Buy |
2,204
+168
| +8% | +$12.5K | 0.04% | 144 |
|
|
2016
Q1 | $136K | Buy |
2,036
+177
| +10% | +$11.8K | 0.03% | 173 |
|
|
2015
Q4 | $126K | Buy |
1,859
+136
| +8% | +$9.22K | 0.03% | 184 |
|
|
2015
Q3 | $92K | Hold |
1,723
| – | – | 0.02% | 209 |
|
|
2015
Q2 | $108K | Buy |
+1,723
| New | +$108K | 0.02% | 208 |
|